Definium Therapeutics Inc

Financials

Gesamtvermögen 164 M169.99 M124.54 M302.15 M440.1 M Gesamtverbindlichkeiten 12.34 M19.08 M46.41 M60.7 M107.77 M Gesamtkapital 151.66 M150.92 M78.13 M241.45 M332.33 M Gesamtverbindlichkeiten und Eigenkapital 164 M169.99 M124.54 M302.15 M440.1 M Gesamtverschuldung ——14.13 M21.85 M40.58 M Nettoverschuldung ——-85.58 M-251.89 M-371.01 M

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.